In Session with Dr. David Meagher: Current Evidence on Pharmacotherapy for Delirium David Meagher, MD, PhD Department of Adult Psychiatry, University Hospital Limerick, Ireland Disclosure: Dr. Meagher reports no affiliations with, or financial interests in, any organization that may pose a conflict of interest. This article includes discussion of off-label treatment with atypical antipsychotics. PP:…
Read >
When Working Memory isn’t Working: How and Why, and What it Means for Patients with Schizophrenia Stephen I. Deutsch, MD, PhD Anne Armistead Robinson Endowed Chair in Psychiatry; Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Eastern Virginia Medical School; Attending Psychiatrist, Sentara Norfolk General Hospital, Norfolk, Va. Disclosure: Dr. Deutsch has received grant…
Read >
One-Year Mother & Baby Outcomes Following Antipsychotic Use in Pregnancy Jayashri Kulkarni, MBBS, MPM, FRANZCP, PhD Director, Monash Alfred Psychiatry Research Centre, Melbourne, Australia
Psychopharmacology in Treating Posttraumatic Stress Disorder with Co-occuring Mild Traumatic Brain Injury Paul S. Hammer, MD Captain, Medical Corps, US Navy; Navy Medicine Information Systems Support Activity, San Antonio, TX William M. Sauvé, MD Medical Director, TMS NeuroHealth Centers of Richmond, VA Disclosure: This article discusses off-label medication use. Dr. Hammer reports no affiliations with,…
Read >
Bupropion: 5 tips By Flavio Guzman, MD Editor, Psychopharmacology Institute In this psychopharmacology refresher series, from the Psychopharmacology Institute, we discuss key aspects of commonly used medications. Today we start with 5 important concepts about bupropion. 1. Non-serotonergic. It does not influence serotonergic neurotransmission: it is a norepinephrine dopamine reuptake inhibitor without activity on…
Read >
Why Patients Choose Psychotherapy or Sertraline: From a Clinical Trial of PTSD Treatment Stephanie Keller, MA Doctoral Candidate; Department of Psychological Sciences, Case Western Reserve University, OH First published in Psychiatry Weekly, October 21, 2013, 8(22). Introduction Why do some psychiatric patients prefer a particular treatment modality—or modalities—to another? This question is particularly conspicuous in…
Read >
The FDA has approved a new SNRI for major depressive disorder in adults. FDA Approvals
Read >
Based on EEG technology, the NEBA System calculates the ratio of 2 brain waves that can help clinicians more accurately diagnose ADHD. FDA Approvals
Read >
Older patients with generalized anxiety disorder on maintenance escitalopram have a better chance of avoiding relapse when going off the medication if they are also receiving cognitive behavioral therapy. Reuters Health Information
Read >
There is well-established evidence of a P50 sensory gating deficit in patients of schizophrenia. This gating deficit refers broadly to an inability to prioritize environmental stimuli. More specifically, it refers to an inability to dampen the amplitude of the evoked P50 potential to the second of a pair of identical auditory stimuli presented 500 milliseconds…
Read >
When the DSM-5 is released this month, the diagnostic manual’s first major revision in nearly two decades, there will be a number of changes in the manual’s approach to schizophrenia and other psychotic disorders. Dr. Rajiv Tandon, a member of the DSM-5 Workgroup for Psychotic Disorders, highlights four important changes that will have clinical implications…
Read >
Patients with certain types of noncancer pain, including back pain, migraine, and psychogenic pain, have been found to have a significantly increased risk for suicide, new research suggests. Medscape Medical News
Read >
This supplement is supported by Pamlab LLC. Question-and-Answer Session Q: Studies are showing that treatment initiated when pre-dementia or early memory loss is recognized leads to a better prognosis than waiting to initiate treatment once Alzheimer’s disease (AD) or dementia is established. What options do clinicians have to address early memory loss? …
Read >
Parents Report Inadequate Support in Schools for Behavioral and Emotional Issues Children with behavioral, emotional, or family problems typically first seek support from school psychologists, counselors, and social workers. Behavioral problems, including attention-deficit/hyperactivity disorder (ADHD), along with emotional and family problems, bullying, and homelessness, can negatively impact children’s academic success. Approximately 1,100 parents across the…
Read >
Childhood-Onset Social Anxiety Disorder Associated With Later Development of Major Depressive Disorder According to the National Institute of Mental Health, social anxiety disorder (SAD), also called social phobia, affects approximately 15 million American adults ≥18 years of age. The disorder, which is characterized by extreme anxiety and self-consciousness in response to everyday social situations,…
Read >
Letter to the Editor Print Friendly Modafinil-Induced Mania in a Patient with Bipolar Affective Disorder Return August 5, 2007 To the Editor: Modafinil has been approved for the treatment of excessive daytime sleepiness associated with narcolepsy, shift-work sleep disorder, and obstructive sleep apnea/hypopnea syndrome. The notable side effects of modafinil use are headache, nervousness, anxiety,…
Read >
Potential New Alzheimer’s Disease Diagnostic Criteria Determined Data presented at the Alzheimer’s Association’s International Conference on Alzheimer’s Disease 2010 hopes to change the way physicians diagnose Alzheimer’s disease as well as provide a diagnosis well before symptoms are evident. The Alzheimer’s Association wants to develop new diagnostic criteria based on the current theory that Alzheimer’s…
Read >
Patients and Their Family Members Endure Psychological Distress Post-ICU Care Approximately 4 million Americans are admitted to the Intensive Care Unit (ICU) each year. While there have been numerous advances in ICU treatment, life for patients and their family members post-ICU care is seldom addressed. Two studies, one led by Dimitry S. Davydow, MD, of…
Read >
Psychiatric Dispatches Print Friendly Psychiatric Dispatches: Noteworthy Briefs from the Field: April 2009 Return Primary Psychiatry. 2009;16(4):17-18 Depression Linked to Increase in Harmful Type of Body Fat While obesity and weight gain have been known to be a common link to depression, depression is also actually proven to increase fat. Nicole Vogelzangs, doctoral student…
Read >
This interview took place on September 6, 2007, and was conducted by Norman Sussman, MD. This interview is also available as an audio PsychCastTM at http://psychcast.mblcommunications.com. Disclosure: Dr. Goldberg is consultant to Abbott, AstraZeneca, Cephalon, Eli Lilly, and GlaxoSmithKline; on the speaker’s bureaus of Abbott, AstraZeneca, Eli Lilly, and GlaxoSmithKline; and on the…
Read >
Background Mindfulness-based interventions show promise for stress reduction in general medical conditions, and initial evidence suggests that they are accepted in trauma-exposed individuals. Mindfulness-based cognitive therapy (MBCT) shows substantial efficacy for prevention of depression relapse, but it has been less studied in anxiety disorders.
Read >
Users of illicit drugs are now combining xylazine with other drugs of abuse and may be increasing their risk of death, according to new research. Reuters Health Information
Read >
High-intensity sunlight appears to be associated with a lower prevalence of ADHD, new research shows. Medscape Medical News
Read >
In the wake of the Academy Awards, Dr. Jeffrey Lieberman reviews 2 recent movies portraying mental illness.
Read >
Depressive symptoms attenuate the anti-inflammatory effects of physical activity and light to moderate alcohol consumption, a new study suggests. Medscape Medical News
Read >